Maryam Samareh Salavati Pour

Maryam Samareh Salavati Pour

Auto-generated profile, based on publicly available information

Maryam Samareh Salavati Pour

Department of Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 March 2024 in BioImpacts
Verified
Journal Article
Open access
PDF file
MSMaryam Samareh Salavatipour
Maryam Samareh Salavatipour
ZPZahra Poursalehi
Zahra Poursalehi
NRNegin Hosseini Rouzbahani
Negin Hosseini Rouzbahani
SMSohaib Mohammadyar
Sohaib Mohammadyar
MVMohammad Vasei
Mohammad Vasei
Introduction: The discovery of gene editing techniques has opened a new era within the field of biology and enabled scientists to manipulate nucleic acid molecules. CRISPR-Cas9 genome engineering has revolutionized this achievement by successful targeting the DNA molecule and editing its sequence. Since genomic changes are the basis of the birth and growth of many tumors, CRISPR-Cas9 method has been successfully applied to identify and manipulate the genes which are involved in initiating and driving some neoplastic processes. Methods: By review of the existing literature on application of CRISPR-Cas9 in cancer, different databases, such as PubMed and Google Scholar, we started data collection for "CRISPR-Cas9", "Genome Editing", "Cancer", "Solid tumors", "Hematologic malignancy" "Immunotherapy", "Diagnosis", "Drug resistance" phrases. Clinicaltrials.gov, a resource that provides access to information on clinical trials, was also searched in this review. Results: We have defined the basics of this technology and then mentioned some clinical and preclinical studies using this technology in the treatment of a variety of solid tumors as well as hematologic neoplasms. Finally, we described the progress made by this technology in boosting immune-mediated cell therapy in oncology, such as CAR-T cells, CAR-NK cells, and CAR-M cells. Conclusion: CRISPR-Cas9 system revolutionized the therapeutic strategies in some solid malignant tumors and leukemia through targeting the key genes involved in the pathogenesis of these cancers.

1 August 2021 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
MPMaryam Samareh Salavati Pour
Maryam Samareh Salavati Pour
FKFatemeh Hoseinpour Kasgari
Fatemeh Hoseinpour Kasgari
AFAlireza Farsinejad
Alireza Farsinejad
AFAhmad Fatemi
Ahmad Fatemi
GHGholamhossein Hassanshahi
Gholamhossein Hassanshahi
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi
Background: Due to their self-renewal and differentiation ability, the mesenchymal stem cells (MSCs) have been studied extensively. However, the MSCs lifespan is restricted; they undergo several divisions in vitro that cause several alternations in cellular features and relatively lessens their application. Thus, this study was aimed to assess the effect of platelet-derived microparticles (PMPs), a valuable source of proteins, microRNAs (miRNAs), and growth factors, on the expression of hTERT, c-MYC, p16, p53, and p21 as the most important aging and cell longevity genes alongside with population doubling time (PDT) of PMP-treated cells in comparison to a control group. Methods: Umbilical cord MSCs (UC-MSCs) were used in this study, whereby they reached a confluency of 30%. MSCs were treated by PMPs (50 µg/mL), and then, PDT was determined for both groups. Quantitative expression of hTERT, c-MYC, p16, p53, and p21 was examined through quantitative real-time PCR at various intervals (i.e. after five and thirty days as well as freezing-thawing process). Results: Our results demonstrated that the treated group had a shorter PDT in comparison to the control group (P<0.050). The real-Time PCR data also indicated that PMPs were able to remarkably up-regulate hTERT and c-MYC genes expression while down-regulating the expression of p16, p21, and p53 genes (P<0.050), especially following five days of treatment. Conclusion: According to these data, it appears that PMPs are a safe and effective candidate for prolonging the lifespan of UC-MSCs; however, further investigations are needed to corroborate this finding.

10 October 2018 in Research in Molecular Medicine
Verified
Journal Article
Closed access
MPMaryam Samareh Salavati Pour
Maryam Samareh Salavati Pour
FKFatemeh Hoseinpour Kasgari
Fatemeh Hoseinpour Kasgari
AFAlireza Farsinejad
Alireza Farsinejad
AFAhmad Fatemi
Ahmad Fatemi
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi
Introduction: Mesenchymal stem cells (MSCs) are widely studied due to their self- renewal potential and capacity to differentiate into multiple tissues. However, they have a limited life span of several divisions in vitro, which alters various cellular characteristics and reduces their application. Aim: We evaluated the effect of platelet-derived microparticles on gene expression of hTERT, one of the main factors involved in aging and cell longevity. Materials and methods: Umbilical cord MSCs were used for this study. Cells were characterized by evaluating morphology via inverted microscope and identifying associated surface markers using flow cytometry. Platelet-derived microparticles were prepared by centrifuging platelet bags at varying speeds, and their concen- trations were determined by Bradford assay. At 30% confluency, MSCs were treated with 50 μg/mL of microparticles for five days. Then, RNA was extracted and cDNA was synthesized. Quantitative expression of hTERT was assessed using real-time polymerase chain reaction (PCR). Results: Fibroblast-like cells were isolated from umbilical cord tissue and MSCs were identified by the presence of mesenchymal surface markers via flow cytometry. Real- time PCR showed that gene expression of hTERT increased by more than three times when treated with platelet-derived microparticles, in comparison to expression of the control group. Conclusion: We concluded that platelet-derived microparticles may be a potentially safe and effective method to increase hTERT gene expression in MSCs, ultimately prolonging their life span in vitro.

12 February 2019 in Indian Journal of Hematology and Blood Transfusion
Verified
Journal Article
Closed access
PDF file
MPMaryam Samareh Salavati Pour
Maryam Samareh Salavati Pour
SSSaeed Soleimany
Saeed Soleimany
NGNarges Ghasemimehr
Narges Ghasemimehr
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi

1 September 2018 in Journal of Medical Microbiology
Verified
Journal Article
Closed access
HHHossein Hosseini-Nave
Hossein Hosseini-Nave
MSMaryam Samareh Salavati
Maryam Samareh Salavati
MLMahla Lashkari
Mahla Lashkari
MRMehrnaze Alsadat Ravari
Mehrnaze Alsadat Ravari
ZHZahra Hashemizadeh
Zahra Hashemizadeh
FMFahimeh Mohseni
Fahimeh Mohseni
Purpose. Entero-aggregative Escherichia coli (EAEC) is one of the main causes of diarrhoea worldwide. Several virulence factors have been identified in EAEC. This study was conducted to investigate the distribution of virulence factor genes in EAEC strains isolated in Iran from children with diarrhoea, as well as the genetic similarity of these isolates. Methodology. A total of 37 EAEC isolates were tested for the presence of 11 virulence genes by PCR, and the genetic relatedness of these strains was further determined by multilocus variable-number tandem-repeat analysis (MLVA). Results. All EAEC isolates were typical EAEC. pic, set1A and set1B were the most prevalent genes, detected in 54.1 % of the isolates, followed by sat (43.2 %), astA (32.4 %), pet (24.3 %), agg4A (24.3 %), sepA (18.9 %), agg3A (13.5 %), sigA (8.1 %), aggA (8.1 %) and aafA (5.4 %). Using MLVA, the 37 isolates were divided into 32 types and classified into five clonal complexes. Conclusion. This study showed that EAEC is a heterogeneous group of E. coli possessing a broad range of virulence factors. There was no notable association between MLVA patterns and virulence profiles.

10 October 2018 in Research in Molecular Medicine
Verified
Journal Article
Closed access
FKFatemeh Hoseinpour Kasgari
Fatemeh Hoseinpour Kasgari
MPMaryam Samareh Salavati Pour
Maryam Samareh Salavati Pour
AFAlireza Farsinejad
Alireza Farsinejad
AFAhmad Fatemi
Ahmad Fatemi
RKRoohollah Mirzaee Khalilabadi
Roohollah Mirzaee Khalilabadi
Ntroduction: Due to high differentiation potential and self-renewality, Mesenchymal stem cells are now widely considered by researchers in several diseases. FBS is used as a supplement in culture media for proliferation, differentiation, and other culture processes of MSCs, which is associated with transmission risk of a variety of infections as well as immune responses. PRGF derived from platelets contains growth factors causing the growth and proliferation of MSCs. This study was conducted to compare the effect of PRGF in comparison to FBS on the expression of h-TERT gene, in umbilical cord-derived MSCs. Materials and Methods: This study is an experimental research. Four expired platelet concentrate bags were obtained from Kerman blood transfusion center, and PRGF was prepared by multiple centrifugation rounds of the platelet bag. Calcium chloride was added as an anticoagulant to PRGF in order to prevent gelatinization of the culture medium. On the other hand, mesenchymal stem cells were isolated from the umbilical cord as a primary culture. The phenotype of the cells was confirmed by flow cytometry, and the cells were randomly cultured as control (using FBS) and experimental (using PRGF) groups. The expression of the gene involved in increasing cell longevity (h-TERT) was investigated by real-time PCR technique after six days. Results: Mesenchymal stem cells were successfully isolated from the umbilical cord. Morphologically, the mesenchymal cells cultured in the experimental group (using PRGF) were similar to the cells in the control medium. The cells exhibited a high expression level of CD73, CD90, and CD105, while the surface markers of hematopoietic cells such as CD45 and CD34 were slightly expressed. Therefore, there was no significant difference in the expression of cell surface markers between control and experimental groups. In this study, using the real-time PCR technique, it was shown that PRGF derived from the platelet could increase the expression of h- TERT gene in the umbilical cord mesenchymal stem cells compared with the control. (P = 0.034)